See All Slides - tctmd.com

Slides

Presentation TCT 2012

Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety

Presenter: Ajay Kirtane

October 23, 2012

Presentation TCT 2012

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

Presenter: Andrej Schmidt

October 23, 2012

Presentation TCT 2012

TCT-51. Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-eluting Stents: Insight from the Florence Left Main-PCI...

Presenter: Renato Valenti

October 23, 2012

Presentation TCT 2012

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Presenter: Bernard De Bruyne

October 23, 2012

Presentation TCT 2012

Case 1: During a TAVR

Presenter: Susheel Kodali

October 23, 2012

Presentation TCT 2012

TCT-7. Plaque Excision as a Treatment Option for Critical Limb Ischemia: 1-Year Results of the DEFINITIVE LE Study

Presenter: James McKinsey

October 23, 2012

Presentation TCT 2012

TCT-371. First Clinical Evaluation of a Novel Percutaneous Right Ventricular Assist Device: The Impella RP

Presenter: Anson Cheung

October 23, 2012

Presentation TCT 2012

TCT-71. Intravascular Ultrasound-guided Systematic Two-stent Techniques for Coronary Bifurcation Lesions Reduced Late Stent Thrombosis and ST-elevation Myocardial Infarction

Presenter: Shao Liang Chen

October 23, 2012

Presentation TCT 2012

NIRS as a Clinical Tool for Vulnerable Plaque Detection: Findings in Patients with Acute STEMI

Presenter: Ryan Madder

October 23, 2012

Presentation TCT 2012

Vulnerable Plaque Is a Systemic Inflammatory and Vascular Disease

Presenter: Valentin Fuster

October 23, 2012

Advertisement

Slides

Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

TCT-51. Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-eluting Stents: Insight from the Florence Left Main-PCI...

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Case 1: During a TAVR

TCT-7. Plaque Excision as a Treatment Option for Critical Limb Ischemia: 1-Year Results of the DEFINITIVE LE Study

TCT-371. First Clinical Evaluation of a Novel Percutaneous Right Ventricular Assist Device: The Impella RP

TCT-71. Intravascular Ultrasound-guided Systematic Two-stent Techniques for Coronary Bifurcation Lesions Reduced Late Stent Thrombosis and ST-elevation Myocardial Infarction

NIRS as a Clinical Tool for Vulnerable Plaque Detection: Findings in Patients with Acute STEMI

Vulnerable Plaque Is a Systemic Inflammatory and Vascular Disease

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content